1. Ministry of Health and Welfare. Korea Centers for Disease Control and Prevention. 2008 National Health Statistics-The Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV-2) (2008). 2009. Seoul: Korea Centers for Disease Control and Prevention; p. 22-23.
2. U. S. Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics. Health, United States, 2009: with special feature on medical technology. 2010. Maryland: National Center for Health Statistics (US); p. 286-288.
3. Lee CH. The Korean Socienty of Gastroenterology. Perspectives of chronic liver disease in Korea. Hepatitis. 2005. 2nd ed. Seoul: Koonja; p. 1-2.
4. Kim KA. Current status of liver diseases in Korea: toxic and alcoholic liver diseases. Korean J Hepatol 2009;15(Suppl 6):S29-S33. 20037277.
5. Purohit V, Brenner DA. Mechanisms of alcohol-induced hepatic fibrosis: a summary of the Ron Thurman Symposium. Hepatology 2006;43:872-878. 16502397.
7. Müller C. Liver, alcohol and gender. Wien Med Wochenschr 2006;156:523-526. 17103288.
8. Branton MH, Kopp JB. TGF-beta and fibrosis. Microbes Infect 1999;1:1349-1365. 10611762.
9. Oliver J, Agúndez JA, Morales S, Fernández-Arquero M, Fernández-Gutierrez B, de la Concha EG, et al. Polymorphisms in the transforming growth factor-beta gene (TGF-beta) and the risk of advanced alcoholic liver disease. Liver Int 2005;25:935-939. 16162149.
10. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998;66:1014-1020. 9808485.
11. Cambien F, Ricard S, Troesch A, Mallet C, Générénaz L, Evans A, et al. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 1996;28:881-887. 8901839.
12. Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD, Crawford DH, Shorthouse C, et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 2000;31:828-833. 10733535.
13. Gewaltig J, Mangasser-Stephan K, Gartung C, Biesterfeld S, Gressner AM. Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta 2002;316:83-94. 11750277.
14. Kwon OS, Song SH, Ju KT, Chung MG, Park DK, Kim SS, et al. Polymorphism in codons 10 and 25 of the transforming growth factor-beta1 gene in Korean population and in patients with liver cirrhosis and hepatocellular carcinoma. Korean J Gastroenterol 2003;42:212-219. 14532743.
15. Zhang Y, Liu B, Jin M, Ni Q, Liang X, Ma X, et al. Genetic polymorphisms of transforming growth factor-beta1 and its receptors and colorectal cancer susceptibility: a population-based case-control study in China. Cancer Lett 2009;275:102-108. 19036501.
16. Kikuchi K, Tanaka A, Matsushita M, Kitazawa E, Hosoya N, Kawashima Y, et al. Genetic polymorphisms of transforming growth factor beta-1 promoter and primary biliary cirrhosis in Japanese patients. Ann N Y Acad Sci 2007;1110:15-22. 17911416.
17. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000;342:1350-1358. 10793168.
19. Bissell DM, Roulot D, George J. Transforming growth factor beta and the liver. Hepatology 2001;34:859-867. 11679955.
20. McCullough AJ. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Alcoholic liver disease. Schiff's Diseases of the Liver. 1999. Vol 2: 8th ed. Philadelphia: Lippincott-Raven; p. 941-972.
21. Norton R, Batey R, Dwyer T, MacMahon S. Alcohol consumption and the risk of alcohol related cirrhosis in women. Br Med J (Clin Res Ed) 1987;295:80-82.
23. Yamada Y, Miyauchi A, Goto J, Takagi Y, Okuizumi H, Kanematsu M, et al. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 1998;13:1569-1576. 9783545.
24. Yamada Y, Okuizumi H, Miyauchi A, Takagi Y, Ikeda K, Harada A. Association of transforming growth factor beta1 genotype with spinal osteophytosis in Japanese women. Arthritis Rheum 2000;43:452-460. 10693888.
25. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y. Association of a T29→C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000;101:2783-2787. 10859282.
27. Suzuki S, Tanaka Y, Orito E, Sugauchi F, Hasegawa I, Sakurai M, et al. Transforming growth factor-beta-1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 2003;18:1139-1143. 12974899.
28. Migita K, Miyazoe S, Maeda Y, Daikoku M, Abiru S, Ueki T, et al. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J Hepatol 2005;42:505-510. 15763337.
29. Bathgate AJ, Pravica V, Perrey C, Hayes PC, Hutchinson IV. Polymorphisms in tumour necrosis factor alpha, interleukin-10 and transforming growth factor beta1 genes and end-stage liver disease. Eur J Gastroenterol Hepatol 2000;12:1329-1333. 11192323.
30. Baraona E, Abittan CS, Dohmen K, Moretti M, Pozzato G, Chayes ZW, et al. Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res 2001;25:502-507. 11329488.
32. Kim YJ, Lee HS, Im JP, Min BH, Kim HD, Jeong JB, et al. Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med 2003;35:196-202. 12858019.
33. Midanik L. The validity of self-reported alcohol consumption and alcohol problems: a literature review. Br J Addict 1982;77:357-382. 6762224.